AM-Pharma B.V., a Dutch developer of treatment for acute kidney injury, has raised additional funding of $52 million, increasing its recent total tally to $176 million. AM-Pharma’s backers include Cowen Healthcare Investments, LSP, Andera Partners, Forbion, Ysios Capital, Kurma Partners, ID Invest Partners, BB Pureos Bioventures and Gilde Healthcare.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: